GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » UXN Co Ltd (XKRX:337840) » Definitions » Debt-to-EBITDA

UXN Co (XKRX:337840) Debt-to-EBITDA : 1.44 (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is UXN Co Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

UXN Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₩4,624.0 Mil. UXN Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₩244.2 Mil. UXN Co's annualized EBITDA for the quarter that ended in Dec. 2024 was ₩3,375.5 Mil. UXN Co's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2024 was 1.44.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for UXN Co's Debt-to-EBITDA or its related term are showing as below:

XKRX:337840' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -3.88   Med: -0.37   Max: 1.44
Current: 1.44

During the past 3 years, the highest Debt-to-EBITDA Ratio of UXN Co was 1.44. The lowest was -3.88. And the median was -0.37.

XKRX:337840's Debt-to-EBITDA is ranked worse than
50.57% of 439 companies
in the Medical Devices & Instruments industry
Industry Median: 1.42 vs XKRX:337840: 1.44

UXN Co Debt-to-EBITDA Historical Data

The historical data trend for UXN Co's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

UXN Co Debt-to-EBITDA Chart

UXN Co Annual Data
Trend Dec22 Dec23 Dec24
Debt-to-EBITDA
-3.88 -0.37 1.44

UXN Co Semi-Annual Data
Dec22 Dec23 Dec24
Debt-to-EBITDA -3.88 -0.37 1.44

Competitive Comparison of UXN Co's Debt-to-EBITDA

For the Medical Devices subindustry, UXN Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


UXN Co's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, UXN Co's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where UXN Co's Debt-to-EBITDA falls into.


;
;

UXN Co Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

UXN Co's Debt-to-EBITDA for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(4623.992 + 244.239) / 3375.496
=1.44

UXN Co's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(4623.992 + 244.239) / 3375.496
=1.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is one times the quarterly (Dec. 2024) EBITDA data.


UXN Co  (XKRX:337840) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


UXN Co Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of UXN Co's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


UXN Co Business Description

Traded in Other Exchanges
N/A
Address
No. 614, No. 1, 379, Green-ro, Jeollanam-do, Naju, KOR, 58325
UXN Co Ltd is a medical device company. It is engaged in the production of Blood glucose sensors, and blood glucose meter.

UXN Co Headlines

No Headlines